GI Dynamics wins funds to wrap up EndoBarrier device study

07/5/2013 | American City Business Journals

Australian investors and other backers worldwide have pumped $52 million into GI Dynamics. The company will use the funding to wrap up a 500-participant pivotal study of EndoBarrier, a device already approved in certain countries in Europe as well as Chile and Australia for use in treating patients with obesity and type 2 diabetes.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Chief Executive Officer
UCare Minnesota
Minneapolis, MN
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC